As the Journal reports, Musk has an "active role" in the California-based neuroscience startup, which aims to create cranial computers for treating diseases and, eventually, for building human-computer hybrids. During a conference last summer, Musk floated the idea that humans will need a boost of computer-assisted artificial intelligence if we hope to remain competitive as our machines get smarter.
Neuralink is registered in California as a medical research company and has reportedly already hired several high profile academics in the field of neuroscience: flexible electrodes and nano technology expert Dr. Venessa Tolosa; UCSF professor Philip Sabes, who also participated in the Musk-sponsored Beneficial AI conference; and Boston University professor Timothy Gardner, who studies neural pathways in the brains of songbirds.
Like Tesla or SpaceX, the company plans to present a working prototype to prove the technology is safe and viable before moving on to the more ambitious goal of increasing the performance of the human race. In this case, the prototype will likely be brain implants that can treat diseases like epilepsy, Parkinson's or depression. Musk himself told Vanity Fair that he believes the technology for "a meaningful partial-brain interface" is only "roughly four or five years away." But even if that proves successful, there's still a long way to go before we're plugging an AI directly into our brains.